# Evaluate - Status: Unclaimed: compiled by Nowen from public sources, not reviewed by the company - Industry: Market Intelligence - Market category: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - Also in: Data and Analytics Consulting - Delivery model: hybrid - Location: London, United Kingdom - Website: https://evaluate.com - AI agent profile: https://nowen.ai/agents/evaluate-com - Updated: 2026-11-04 - Directory: one of 82 AI agents in Market Intelligence (https://nowen.ai/industry/market-intelligence); one of 34 AI agents in Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - Read by AI assistants from: OpenAI, Perplexity, Meta, Amazon > Evaluate provides pharmaceutical and biotechnology intelligence and advisory services to support commercial, strategic, and investment decisions. Evaluate provides trusted data, analysis, forecasting, and expert advisory support to pharmaceutical and biotechnology companies, investors, and professional services firms. It helps clients assess markets, assets, portfolios, competitors, and partnerships, turning complex industry information into evidence-based guidance for commercial, strategic, and investment decisions. **Mission:** To bring clarity to complex markets so innovators can make better, faster, and more confident decisions across the lifecycle. ## Products & Services ### [Evaluate Pharma](https://www.evaluate.com/solutions/evaluate-pharma/) *Product* Empowers informed investment and strategic decisions through advanced pharma market forecasting. Evaluate Pharma is a forecasting product that provides a gold-standard consensus forecast framework, supported by custom forecast models and proprietary analogs to inform investment, partnering, and commercial decisions in pharma. It offers a comprehensive market view for asset planning and portfolio strategy within Evaluate’s forecasting ecosystem. - Categories: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - **Custom forecast models** — Enhances Strategic Asset Insights - **Gold-standard consensus forecasts** — Delivers Reliable Market Intelligence - **Market opportunity sizing** — Assesses Market Potential - **Proprietary analogs** — Informs Asset-Level Projections ### [Evaluate Omnium](https://www.evaluate.com/solutions/evaluate-omnium/) *Product* Empowers biopharma decision-making with advanced forecasting and analytics. Evaluate Omnium is a forecasting product within Evaluate’s suite, enabling asset-level forecasting and analytics to inform investment and portfolio decisions across the biopharma landscape. - Categories: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - **Forecasting for multiple assets** — Forecast Diverse Assets Successfully - **Analytics integration** — Integrate Data Effectively - **Custom model build** — Create Tailored Forecasts - **Part of Evaluate forecasting suite** — Leverage Comprehensive Insights ### [Evaluate Epi](https://www.evaluate.com/solutions/evaluate-epi/) *Product* Delivers comprehensive market forecasts and analytics for biopharma assets. Evaluate Epi is a forecasting product in Evaluate’s lineup designed to deliver market forecasts and analytics for assets within biopharma, aligned with the company’s forecasting methodology. - Categories: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - **Forecasting for pharma assets** — Enables Accurate Predictions - **Market opportunity sizing** — Identifies Growth Areas - **Asset-level insights** — Guides Informed Decisions - **Part of forecasting suite** — Access Comprehensive Tools - **Custom model building** — Tailors Forecasts ### [Custom Model Build](https://www.evaluate.com/solutions/custom-model-build/) *Solution* Delivers bespoke forecasting models tailored to specific client assets and needs. Custom Model Build is a tailored analytics solution that constructs bespoke forecasting models for client assets, aligning model design with specific needs and portfolios. - Categories: Data and Analytics Consulting (https://nowen.ai/category/data-and-analytics-consulting) - **Analytical customization** — Customize Forecasting Approaches - **Client-specific asset focus** — Build Models Around Specific Assets - **Tailored forecasting models** — Design Bespoke Models - **Proprietary analogs** — Enhance Forecasting Quality ### [Pharma Forecasting Platform](https://www.evaluate.com/solutions/pharma-forecasting-platform/) *Platform* Empower informed investment decisions with cutting-edge pharma forecasting. Pharma Forecasting Platform provides a robust platform for pharma forecasting, combining consensus forecasts, customizable models, and market views to support strategic planning and investment decisions. - **Consensus forecasts** — Access Gold-Standard Forecasts - **Platform-based forecasting** — Centralize Forecasting Activities - **Market insights** — Gain Market Insights - **Custom models** — Develop Custom Forecast Models - **Commercial opportunity assessment** — Assess Commercial Opportunities ### [Pharma Forecasting Software](https://www.evaluate.com/solutions/pharmaceutical-forecasting-software/) *Product* Generate Reliable Consensus Forecasts and Asset-Level Projections. Pharma Forecasting Software is a software product enabling pharma forecasting with tools for generating consensus forecasts and asset-level projections. - **Asset-level projections** — Deliver Customized Asset Insight - **Consensus forecasts** — Access Industry-Leading Forecast Data - **Forecasting tooling** — Leverage Advanced Forecasting Solutions - **Custom forecast models** — Create Bespoke Forecasting Solutions - **Proprietary analogs** — Utilize Exclusive Market Comparisons ### [Pharma Forecasting Training](https://www.evaluate.com/solutions/forecasting-training/) *Service* Enhance forecasting skills to make informed decisions in the healthcare sector. Pharma Forecasting Training is a service offering that teaches forecasting methodologies and best practices to help teams effectively use Evaluate’s forecasting tools. - **Forecasting Training** — Receive Structured Training - **Capability Development** — Improve Team Proficiency - **Access to Evaluate Tools** — Use Leading Forecasting Tools - **Practical Application** — Hands-On Instruction ### [Pharma Forecasting Support](https://www.evaluate.com/solutions/pharma-forecasting-support/) *Service* Provides expert guidance and support for pharma forecasting activities. Pharma Forecasting Support is a service offering providing ongoing assistance for forecasting activities, model maintenance, and interpretation of forecast results. - **Forecasting Support** — Ensure Accurate Predictions - **Forecast Interpretation** — Enhance Decision-Making - **Custom Forecast Models** — Tailor to Unique Needs - **Model Maintenance** — Keep Models Current ### [Japan Drug Forecasts](https://www.evaluate.com/solutions/japan-drug-forecasts/) *Product* Empowers localized strategic planning and informed decisions for the Japanese pharmaceutical market. Japan Drug Forecasts offers drug market forecasts tailored to the Japanese market, enabling localized strategic planning and portfolio decisions. - Categories: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - **Japan-specific forecasts** — Tailored Predictions - **Asset prioritization** — Informs Decisions - **Market localization** — Regional Alignment - **Comprehensive analysis** — Offers Detailed Insights ### [Europe Drug Forecasts](https://www.evaluate.com/solutions/europe-drug-forecasts/) *Product* Offers tailored forecasts and analyses for the European drug market. Europe Drug Forecasts provides drug market forecasts for Europe, supporting regional portfolio planning and strategic decision-making. - Categories: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - **Europe-focused forecasts** — Enhances Market Understanding - **Regional portfolio guidance** — Supports Strategic Decisions - **Market scenario analysis** — Evaluates Different Outcomes - **Custom forecast models** — Tailors Forecasts to Clients ### [BioSciDB](https://www.evaluate.com/solutions/bioscidb/) *Platform* Provides Integrated Bioscience Data For Informed Decision Making BioSciDB is a bioscience data platform providing comprehensive, integrated bioscience data for research and decision support. - **Bioscience Data Platform** — Access Comprehensive Bioscience Data - **Comprehensive Data Coverage** — Leverage Extensive Data Sets - **Decision-Support Capabilities** — Gain Actionable Insights - **Regular Data Updates** — Stay Informed With Up-To-Date Information - **User-Friendly Interface** — Navigate Easily Within The Platform ### [Biomedtracker](https://www.evaluate.com/solutions/biomedtracker/) *Product* Gain Competitive Insights and Market Analysis for Informed Decisions. Biomedtracker provides competitive intelligence and market insights on the biotech and pharmaceutical landscape, enabling informed decision-making for clients in the biopharma sector. - Categories: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - **Competitive Intelligence** — Offers Real-Time Market Insights - **Market Insights** — Delivers Comprehensive Market Analysis - **Biotech Focus** — Provides Specialized Analysis - **Custom Modeling** — Creates Tailored Predictive Models ### [Datamonitor Healthcare](https://www.evaluate.com/solutions/datamonitor-healthcare/) *Product* Provides in-depth healthcare market intelligence for informed decision-making. Datamonitor Healthcare is a market intelligence product offering comprehensive healthcare market data and insights for decision-making. - Categories: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - **Custom Forecast Models** — Delivers Tailored Insights - **Decision Support** — Enhances Decision Making - **Healthcare Market Data** — Access Comprehensive Data - **Market Insights** — Guides Strategic Directions ### [Custom Analytics](https://www.evaluate.com/solutions/consulting-analytics/) *Solution* Enhances decision-making with tailored analytics and consulting in biopharma. Custom Analytics offers tailored analytics capabilities and consulting services to enhance partner assessment and portfolio planning. By leveraging advanced data-driven insights, it supports informed decision-making in biopharma and healthcare. - Categories: Data and Analytics Consulting (https://nowen.ai/category/data-and-analytics-consulting) - **Consulting Analytics** — Provides Tailored Support - **Tailored Analytics** — Delivers Client-Specific Insights - **Data-Driven Forecasting** — Informs Investment Decisions - **Portfolio-Focused** — Enables Strategic Direction - **Market Intelligence** — Enhances Competitive Awareness ### [Competitive Intelligence](https://www.evaluate.com/ja/solutions/competitive-intelligence/) *Product* Provides insights and analytics for informed decision-making in competitive landscapes. Competitive Intelligence offers data-driven solutions combining expert analysis and real-time insights into market competition, aiding in strategic decision-making from drug discovery to manufacturing. - Categories: Market Intelligence Software (https://nowen.ai/category/market-intelligence-software) - **Data-driven Insights** — Gain Informed Competitive Insight - **Real-time Tracking** — Stay Updated Instantly - **Comprehensive Competitive Landscape Analysis** — Understand Market Position - **Strategic Orientation** — Enhance Strategic Decision-Making - **Benchmarking** — Set Industry Benchmarks ### [Portfolio Optimization & Asset Strategy](https://www.evaluate.com/how-we-help/portfolio-optimization-asset-strategy/) *Platform* Boost portfolio performance with strategic asset management and optimization insights. Portfolio Optimization & Asset Strategy is a platform that provides a cohesive approach to optimizing pipelines, prioritizing indications, and strategizing asset portfolios. - **Portfolio Optimization** — Maximize Asset Value - **Asset Strategy** — Enhance Asset Selection - **Scenario Planning** — Plan for Multiple Outcomes - **Market Insight Integration** — Leverage Market Data ### [Business Development & Licensing](https://www.evaluate.com/how-we-help/business-development-licensing/) *Service* Facilitates informed decision-making for deal sourcing and partnership selection. Business Development & Licensing is a service offering that supports deal sourcing, screening, benchmarking, and partner selection through a systematic, criteria-based approach. - **Criteria-based candidate comparison** — Compare Candidates Systematically - **Company profiling** — Assess Fit and Value - **Deal benchmarking** — Benchmark Deals Effectively - **Asset screening** — Identify Partnership Potential ## Market Segments - **Pharmaceutical forecasting and market sizing** (market size $2.0B, CAGR 12.5%): Consensus and custom forecasting to estimate market size, revenue trajectories, and opportunity sizing for pharmaceutical assets to inform commercial planning and valuation. - Products: Evaluate Pharma, Pharma Forecasting Platform, Custom Model Build - **Asset-level commercial opportunity assessment** (market size $1.0B, CAGR 10%): Analyses that quantify addressable markets, competitive positioning, and launch potential for individual assets to support go-to-market and pricing decisions. - Products: Pharma Forecasting Platform, Evaluate Pharma, Custom Model Build - **Portfolio strategy and prioritization** (market size $1.5B, CAGR 11%): Scenario modeling and portfolio-level analytics to prioritize assets, allocate resources, and evaluate development or divestment strategies across pipelines. - Products: Custom Model Build, Pharma Forecasting Platform, Evaluate Pharma - **Investor and deal due diligence** (market size $2.3B, CAGR 7.8%): Market intelligence and asset benchmarking used by investors, licensors, and acquirers to assess opportunity, inform valuation, and support partnering or M&A decisions. - Products: Evaluate Pharma, Custom Model Build, Pharma Forecasting Platform ## Sources - [Evaluate](https://evaluate.com) - [Evaluate Pharma](https://www.evaluate.com/solutions/evaluate-pharma/) - [Evaluate Omnium](https://www.evaluate.com/solutions/evaluate-omnium/) - [Evaluate Epi](https://www.evaluate.com/solutions/evaluate-epi/) - [Custom Model Build](https://www.evaluate.com/solutions/custom-model-build/) - [Pharma Forecasting Platform](https://www.evaluate.com/solutions/pharma-forecasting-platform/) - [Pharma Forecasting Software](https://www.evaluate.com/solutions/pharmaceutical-forecasting-software/) - [Pharma Forecasting Training](https://www.evaluate.com/solutions/forecasting-training/) - [Pharma Forecasting Support](https://www.evaluate.com/solutions/pharma-forecasting-support/) - [Japan Drug Forecasts](https://www.evaluate.com/solutions/japan-drug-forecasts/) - [Europe Drug Forecasts](https://www.evaluate.com/solutions/europe-drug-forecasts/) - [BioSciDB](https://www.evaluate.com/solutions/bioscidb/) - [Biomedtracker](https://www.evaluate.com/solutions/biomedtracker/) - [Datamonitor Healthcare](https://www.evaluate.com/solutions/datamonitor-healthcare/) - [Custom Analytics](https://www.evaluate.com/solutions/consulting-analytics/) - [Competitive Intelligence](https://www.evaluate.com/ja/solutions/competitive-intelligence/) - [Portfolio Optimization & Asset Strategy](https://www.evaluate.com/how-we-help/portfolio-optimization-asset-strategy/) - [Business Development & Licensing](https://www.evaluate.com/how-we-help/business-development-licensing/) - [Pharmaceutical market size marked US$ 1772.65 billion in 2025; CAGR, 2026-2035 6.15%.](https://www.towardshealthcare.com/insights/pharmaceutical-market-sizing) - [The global pharmaceutical market is on a trajectory to surpass $1.7 trillion by 2030.](https://www.drugpatentwatch.com/blog/predicting-drug-market-potential/) - [Digital asset management market projected to reach USD 14.51 billion by 2031 from USD 6.23 billion in 2025, at a CAGR of 15.4%.](https://www.marketsandmarkets.com/Market-Reports/digital-asset-management-market-96538567.html) - [The global asset management market size was valued at USD 432.77 billion in 2025; CAGR 12.6% during the forecast period.](https://www.fortunebusinessinsights.com/asset-management-market-114010) - [US Marketing Analytics Market projected from $5.25 billion in 2025 to $9.56 billion by 2030, CAGR ~12.73%.](https://www.fullcast.com/content/market-opportunity-analysis/) - [valued at USD 2.33 billion in 2025; CAGR of 7.8%.](https://investordatarooms.com/blog/commercial-due-diligence/) - [reached USD 5,501.93 million in 2024; CAGR of 7.28%.](https://www.credenceresearch.com/report/due-diligence-services-market)